Polyethylene glycol.
A widely used pharmaceutical excipient that improves coating, solubility, and moisture protection in supplements. Improves tablet coating, enhances ingredient solubility, acts as plasticizer for film coatings.
Reviewed March 2026
- Category
- General
- Also filed under
- Improves tablet coatingEnhances ingredient solubilityPlasticizer for film coatings
What Polyethylene Glycol is, and what it does.
- Does it work
- As an excipient it suits any tablet needing a smooth coating or better dissolution. As macrogol powder it suits people wanting an osmotic route to regularity that ferments very little.
- How much to take
- No dose figure is on record for its excipient role, where it is a small fraction of a tablet. Macrogol powders state their own amount on the pack.
- Time to feel it
- It is not an active and has no onset of its own. As a coating it wets and dissolves in the stomach within minutes, which is when the actives behind it become available.
- The first dose
- As a coating it wets and dissolves within minutes, and the actives behind it become available. As macrogol powder it draws water into the bowel and stool softens over the first day.
- With regular use
- As an excipient it adds nothing nutritionally and is not absorbed. As macrogol, softer and more regular stool holds while it is taken, since it works in the bowel rather than on it.
- How well tolerated
- Well tolerated and largely unabsorbed. Allergy to these chains is rare but real, so check with a clinician if you use macrogol regularly or alongside other medicines.
- How it feels
- In a tablet you never notice it at all. As macrogol powder it is tasteless in water, and what you feel is softer stool and less straining rather than cramping.
- The overlooked benefit
- Attaching these chains to a carrier, called PEGylation, wraps it in a water shell that slows clearance and keeps a delivery system circulating longer.
The proof, claim by claim.
What these words mean
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
- Well tolerated excipient
Why these belong in the same formula, 20 pairings
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
Tocophersolan is d-alpha-tocopheryl polyethylene glycol succinate, built by joining vitamin E succinate to a PEG chain. The PEG portion supplies the water-soluble head that makes it a surfactant and solubiliser.
PEG holds water in the bowel lumen osmotically without being absorbed, and bicarbonate is included in the classic PEG electrolyte blend so the water shift does not disturb normal electrolyte balance. The pairing is long-standing pharmacy practice.
Potassium chloride is part of the standard electrolyte set added to high volume PEG solutions so the osmotic water shift does not pull potassium and chloride out of balance. It is formulated in for that reason alone.
Sodium chloride is included alongside PEG so the fluid retained in the lumen is close to isotonic and net sodium movement stays small. Plain PEG without electrolytes shifts more sodium.
PEG works by holding water in the lumen, and a matched electrolyte blend keeps that water shift from disturbing normal sodium, potassium and chloride balance. The two are formulated together for that reason.
Magnesium sulfate is a poorly absorbed osmotic salt and PEG is a poorly absorbed osmotic polymer, so together they hold more water in the lumen than either alone. The additive effect on stool water and on magnesium load is worth spacing.
Sorbitol is absorbed slowly and ferments in the colon while PEG holds water osmotically, so both raise luminal water and gas. Taken together the effect on bowel transit is additive.
Mannitol is very poorly absorbed and acts osmotically in the lumen, the same mechanism PEG uses. Combining them raises luminal water beyond what either contributes on its own.
Ascorbate and ascorbate salts are added to some PEG electrolyte preparations as osmotically active components, which allows a smaller total liquid volume to be swallowed for the same luminal effect. The vitamin here is functioning as an osmotic and flavour component of the vehicle. This is formulation design, not a nutritional pairing.
Psyllium forms a viscous gel by holding water within a fibre matrix, while polyethylene glycol holds water in the lumen osmotically without forming a gel. Taken together they act on stool water content by two different physical routes and both require adequate fluid intake to behave as intended. The combination is common in practice and rests on physical chemistry rather than on a combination trial.
A high-volume osmotic preparation flushes luminal contents through quickly, which shortens the window a delivered organism has to interact with the mucosa. Separating the two by several hours is the usual formulation and dosing response. The transit effect is well described. The size of any consequence for a specific strain is not.
Poorly absorbed magnesium salts such as the sulfate, citrate and hydroxide draw water into the lumen osmotically, the same physical route polyethylene glycol uses. Taken together the osmotic load from the two adds, so the combined fluid shift is larger than from either component on its own. Anyone combining them should account for that.
Fat-soluble vitamin uptake requires bile salt micelle formation and enough contact time with the small intestinal mucosa. A large osmotic load shortens that contact time on the day it is taken. Spacing a fat-soluble vitamin away from an osmotic preparation is standard practice, and the concern is about timing rather than about any lasting change in status.
Non-heme iron is absorbed over a limited stretch of duodenum and needs time in an acidic, reducing environment. Rapid flushing reduces that opportunity on the day of dosing. This is a timing consideration rather than an interaction between the two molecules.
PEG chains grafted onto phospholipids are the standard way to make a lipid particle circulate longer and resist aggregation, and phospholipid-PEG conjugates appear widely in both pharmaceutical and supplement delivery systems. The two components form one amphiphile: a lipid anchor and a hydrophilic PEG corona. The pairing is delivery chemistry, not a nutritional relationship.
Curcuminoids are close to insoluble in water, and PEG-containing surfactant systems are one of the standard ways they are dispersed for oral delivery. The PEG component keeps the active in a solubilised state rather than allowing it to precipitate in gastric fluid. The mechanism is physical solubilisation. The resulting exposure varies by system and should be checked per product.
PEG-based crosslinkers and maleimide-functionalised PEG are used to modify hyaluronan into gels and targeted carriers, work reported in polymer chemistry journals. This is material science applied to topical and injectable products rather than to oral supplementation. Read it as formulation chemistry.
Polyethylene glycol binds condensed and hydrolysable tannins tightly, which is exactly why it is used as a tannin-blocking agent in feed digestibility work. Polyphenol-rich extracts co-ingested with a PEG preparation are therefore liable to be complexed in the lumen. The binding chemistry is well established and the direction is clear even though human co-dosing has not been quantified.
Grape seed proanthocyanidins are condensed tannins, the compound class polyethylene glycol binds most avidly. In laboratory digestibility work PEG is added deliberately to neutralise exactly this chemistry. Co-dosing therefore works against the polyphenol rather than with it.
Polyethylene glycol precipitation is the standard bench method for pulling immunoglobulin-bound vitamin B12 complexes out of serum, which distinguishes a genuinely high B12 from an assay artefact. The interaction is between PEG and the immunoglobulin, not between PEG and the vitamin itself. It is a laboratory technique and has no bearing on oral dosing.
Talk to a doctor before taking Polyethylene Glycol if any of these apply to you: Rare PEG allergies exist, Some consumers prefer PEG-free products. These are flags to check first, not effects Polyethylene Glycol is known to cause.
Not medical advice. Show the label to your pharmacist.What Polyethylene Glycol actually does.
Polyethylene glycol is a chain-like polymer, and its properties depend almost entirely on chain length, with short chains being liquid and longer ones being waxy solids.
3 more mechanisms
Larger polyethylene glycol molecules aren't meaningfully absorbed from the gut or broken down by human enzymes, so they pass through the intestine mostly unchanged.
The polymer holds onto water through hydrogen bonding, drawing water into the gut osmotically rather than acting directly on the bowel wall or nerves.
Polyethylene glycol forms strong bonds with tannins and other polyphenols, which is the basis for its lab use as a tannin-blocking agent.
Where Polyethylene Glycol comes from.
It is a made-in-a-reactor polymer, not something extracted from a plant or an animal. Ethylene oxide units are strung together into chains, and how long those chains are decides whether the result is an oily liquid or a waxy powder. Batches are tested for chain length and for leftover starting material.
What this route gives you
Chemically synthesised. The molecule is identical to the one a plant or an animal makes, and building it deliberately means a known purity, a fixed dose and no crop contaminants. For several nutrients this is the only route that reaches a usable amount.
5 steps on record
Made by catalytic oxidation of ethylene, itself derived from petroleum or natural gas cracking, or in some plants from bio-ethanol dehydration.
Ethylene oxide is polymerised onto a water or glycol initiator under base or acid catalysis. The initiator-to-monomer ratio sets the average chain length and therefore the grade.
Residual catalyst is neutralised and removed, and unreacted ethylene oxide plus by-products such as 1,4-dioxane are stripped, since both are controlled residual limits.
Batches are characterised for average molecular weight and distribution, hydroxyl value, and residual monomer and dioxane against pharmacopoeial limits.
Solid grades are flaked or milled to a defined particle size, liquid grades are filled directly, and electrolyte preparations are blended with the salt base.
Getting Polyethylene Glycol from food.
The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
The forms it comes in.
4 more forms
The essence, in one line each.
- Describes the use of a polyethylene glycol electrolyte solution for managing impacted faecal material and long-standing constipation in veterinary practice. Non-human and uncontrolled.Case series, in animals. Douglas et al., 2026 (Canadian Veterinary Journal). PMID 41716503 ↗
5 more findings
- Used polyethylene glycol as a tannin-binding agent in an in vitro rumen digestibility system, showing how PEG neutralises the effect of dietary tannins on nutrient availability.In vitro study. Kellali et al., 2026 (Animals). PMID 41829057 ↗
- Describes PEG-maleimide grafted onto an amphiphilic chitosan derivative to build a targeted hyaluronan carrier. Polymer chemistry with cell-level testing only.In vitro study. Chen et al., 2026 (Carbohydrate Polymers). PMID 42285660 ↗
- Explains that unexplained high serum vitamin B12 can reflect immunoglobulin-bound macro-B12, and that polyethylene glycol precipitation is the routine bench method used to identify it.Narrative review. Hurkmans et al., 2026 (International Journal of Laboratory Hematology). PMID 41498143 ↗
- Compares erythropoiesis-stimulating agents including PEGylated preparations, where the PEG chain lengthens circulating half-life and allows less frequent dosing.Systematic review. Hassan et al., 2025 (BMC Nephrology). PMID 41249974 ↗
- A narrative review of management approaches in adults under specialist liver care, in which osmotic agents including polyethylene glycol are discussed among the bowel-clearing options.Narrative review. Pyrsopoulos et al., 2026 (Journal of Clinical and Translational Hepatology). PMID 42483733 ↗
Chosen from the 9 we read for Polyethylene Glycol.
The studies, linked.
12 sources behind our Polyethylene Glycol verdict, every one linked to PubMed, the journal or ClinicalTrials.gov.
- ReviewDoes Polyethylene Glycol (PEG) Plus Ascorbic Acid Induce More Mucosal Injuries than Split-Dose 4-L PEG during Bowel Preparation?PubMed ↗Gut and Liver, 2015, cited 19 times, open access
11 more linked trials
- ReviewComparison of Polyethylene Glycol-Electrolyte Solution vs Polyethylene Glycol-3350 for the Treatment of Fecal Impaction in Pediatric Patients.PubMed ↗The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG, 2015, cited 12 times, open access
- ReviewSa1099 Colon Capsule Transit Times and Image Quality in Patients Prepared With Polyethylene Glycol+Ascorbate (PEG+A) and Booster of Either PEG+A or Gastrografin and Low Dose Sodium Phosphate (NaP)DOI ↗Gastroenterology, 2015, cited 1 times
- Source ↗
- ReviewOne Day Polyethylene Glycol-3350 for Bowel Preparation in Pediatrics: A Literature ReviewDOI ↗Open Journal of Pediatrics, 2015, open access
- DOI ↗
- Clinical trialAn Open-label, Multicenter, Randomized Study to Determine Dose Conversion Factors at Different Frequencies of Administration After Switching From Maintenance Treatment With Subcutaneous Epoetin Alfa or Beta to Maintenance Treatment With Subcutaneous RO0503821 in Dialysis Patients With Chronic Renal AnemiaClinicalTrials.gov ↗Phase 2, 137 participants, Completed
- Clinical trialEvaluation of the Efficacy, Tolerability, and Safety of Two Colonoscopy Preparation Regimens in Children With Inflammatory Bowel Disease: a Randomized Study.ClinicalTrials.gov ↗125 participants, Completed
- Clinical trialComparison of Single-dose (Morning) Low-volume Polyethylene Glycol Plus Bisacodyl Versus Split-dose Polyethylene Glycol for Bowel Preparation Efficacy in Patient Receiving Morning ColonoscopyClinicalTrials.gov ↗122 participants, Completed
- Clinical trialTraceIT TM Hydrogel Tissue Marker for Patients Receiving Definitive Chemoradiation for Bladder CancerClinicalTrials.gov ↗12 participants, Completed
- Clinical trialProgesterone for Maintenance Tocolysis: A Randomized Placebo Controlled TrialClinicalTrials.gov ↗Phase 2, 7 participants, Terminated
- Clinical trialA Randomized Controlled Trial Examining Patient Tolerability and Efficacy of Bowel Preparation With Split Dose Picosalax vs. Split Dose Polyethylene GlycolClinicalTrials.gov ↗Phase 4, 5 participants, Terminated
From clinical trials and PubMed, ranked by study type and citation weight, not cherry-picked.
Problems people have reported.
Read this carefully. These are 244,108 voluntary, unverified reactions reported to the FDA (openFDA). The number mostly reflects how popular Polyethylene Glycol is, not how risky it is. A report is not proof Polyethylene Glycol caused anything. It is a signal of what to watch for, nothing more.
3 more reported effects
Source: openFDA adverse-event reports. Voluntary reporting, not an incidence rate.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.